Hair & Nails
Conference Coverage
Data back botulinum toxin for facial flushing, androgenetic alopecia
LAHAINA, HAWAII – “PRP certainly doesn’t do any better” than botulinum toxin for male pattern alopecia.
Pediatric Dermatology Consult
Nail dystrophy and nail plate thinning
The child also had longitudinal fissuring of all fingernails on presentation.
Clinical Review
Effect of In-Office Samples on Dermatologists’ Prescribing Habits: A Retrospective Review
There has been growing concern that pharmaceutical interactions and incentives can influence physicians' prescribing habits. This study aimed to...
Tips
Transillumination for Improved Diagnosis of Digital Myxoid Cysts
Myxoid cysts are among the most common space-occupying lesions involving the nail unit. Transillumination is a valuable techique that may aid...
Case Letter
Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
Epidermal growth factor receptor inhibition may lead to enhanced fragility of the periungual skin and nail plate as well as a proinflammatory...
Case Reports
Remote-Onset Alopecia Areata Attributed to Ipilimumab
Cutaneous immune-related adverse effects (irAEs) are among the most common adverse effects of ipilimumab used to treat advanced-stage melanoma....
Commentary
Updates in Our Understanding of Central Centrifugal Cicatricial Alopecia
For years, many patients with central centifugal cicatricial alopecia (CCCA) have been turned away with few answers and left thinking that it is...
Conference Coverage
Pediatric dermatology update: New research offers insight into psoriasis, alopecia
LAS VEGAS – Children are presenting with TNF inhibitor–induced psoriasis.
News from the FDA/CDC
FDA still concerned about biotin affecting troponin tests
The agency has issued an update to its 2017 safety communication.
Conference Coverage
Expert reviews strategies for diagnosing, treating onychomycosis
LAS VEGAS – The ideal treatment for onychomycosis would not pose a systemic risk to the liver, heart, or other organs, and would not require lab...
Conference Coverage
Oral JAK1/2 inhibitor promising in alopecia areata
MADRID – A host of Janus kinsase inhibitors are in the developmental pipeline for this psychosocially devastating disease, for which at present...